We use cookies to provide you with the best possible experience. By using Orbitax's services, you agree that we may store cookies on your device. Cookie Policy.
The AI assistant for tax questions
Track worldwide tax law changes daily
Cross-border tax analysis and data
Unify and empower your entity management
Provides compliance steps, forms & rates
Visualize and manage your entity data
Comprehensive compliance management
Audit and global tax controversy tracking
Manage reportable cross-border arrangements
Country-by-country reporting & compliance
Pillar 2 planning, reporting and compliance
Calculate US tax impact of foreign operations
Automated workflows for recurring tax tasks
Secure API connections to 3rd-party systems
Secure storage for your tax documentation
Automated tax workflows with secure APIs.
Collaborate securely on your tax data
Share This Article
|
|
The Greek Public Revenue Authority (AADE) has published a notice that a 0% VAT rate is being provided for COVID-19 vaccines and medical devices for in vitro diagnosis of COVID-19, which is valid from 23 December 2020 until 31 December 2022. It is further noted that other vaccines and diagnosis devices not for COVID-19 remain subject to their standard respective VAT rates. The AADE has also published a circular further clarifying that approved COVID-19 products are treated as zero-rated, meaning input tax on supplies may be deducted. The circular also provides that closely related services for these products are zero-rated...